Minoxidil

DRUG18 trials

Sponsors

Johnson & Johnson Consumer and Personal Products Worldwide, University of British Columbia, University of Chicago, Hospices Civils de Lyon, Charite University, Berlin, Germany

Conditions

Anal FissureAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8

Early Phase 1

Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

RecruitingNCT05417308

Ohio State University Comprehensive Cancer CenterAnatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 +20

Start: 2023-03-01End: 2027-12-31Target: 50Updated: 2026-03-10

Phase 1

Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia

Aneira Pharma, Inc.Androgenetic Alopecia

Start: 2023-06-09End: 2023-07-17Target: 14Updated: 2023-05-18

Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon

Not yet recruitingNCT07264790

Duke UniversityBreast Reconstruction, Genetic Predisposition, High Risk for Breast Cancer +1

Start: 2025-12-31End: 2027-09-30Target: 25Updated: 2025-12-04

Phase 2

Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss

CompletedNCT00175617

University of British ColumbiaFemale Pattern Hair Loss

Start: 2005-09-30End: 2009-03-09Target: 40Updated: 2017-03-03

Efficacy of Minoxidil in Children With Williams-Beuren Syndrome

CompletedNCT00876200

Hospices Civils de LyonWilliams Beuren Syndrome

Start: 2009-03-31End: 2015-08-31Updated: 2025-09-30

Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia

CompletedNCT01319370

Natalie GARCIA BARTELSAndrogenetic Alopecia

Start: 2010-11-30End: 2013-03-31Updated: 2013-11-07

Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer

Loyola UniversityOvarian Cancer

Start: 2021-12-13End: 2024-12-31Target: 34Updated: 2023-10-05

Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia

Indonesia UniversityAndrogenetic Alopecia

Start: 2023-05-01End: 2023-12-30Target: 40Updated: 2023-09-22

Phase 3

A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss

CompletedNCT00151515

Johnson & Johnson Consumer and Personal Products WorldwideAndrogenetic Alopecia

Start: 2003-10-31End: 2004-07-31Updated: 2016-09-30

Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia

CompletedNCT00958750

Charite University, Berlin, GermanyAndrogenetic Alopecia, Female Pattern Hair Loss

Start: 2008-06-30End: 2009-06-30Updated: 2011-11-18

Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients

Brasilia University HospitalFemale Pattern Alopecia

Start: 2012-03-31End: 2013-12-31Target: 60Updated: 2013-09-25

Efficacy & Safety of Minoxidil SL Tablets in Men With AGA

RecruitingNCT06924632

Samson Clinical Operations Pty LtdAndrogenetic Alopecia, Male Pattern Baldness

Start: 2025-07-14End: 2026-07-31Target: 132Updated: 2025-07-25

Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia

Not yet recruitingNCT07273799

Sheikh Zayed Federal Postgraduate Medical InstituteAndrogenic Alopecia

Start: 2025-12-20End: 2026-06-01Target: 200Updated: 2025-12-10

Phase 4

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

RecruitingNCT04207931

Wake Forest University Health SciencesCentral Centrifugal Cicatricial Alopecia (CCCA)

Start: 2018-04-30End: 2027-03-01Target: 250Updated: 2026-03-31

Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia

Assiut UniversityAndrogenetic Alopecia

Start: 2020-06-30End: 2021-11-30Target: 60Updated: 2020-03-04

Unknown Phase

Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension

TerminatedNCT00607477

University of ChicagoTreatment Induced Hypertension

Start: 2008-01-31End: 2009-01-31Updated: 2014-06-10

Microarray Analysis of Scalp Biopsies After Minoxidil Treatment

CompletedNCT01309191

University Hospitals Cleveland Medical CenterAndrogenetic Alopecia

Start: 2011-04-30End: 2012-04-30Updated: 2022-04-29

Topical Minoxidil Versus Topical Glyceryl Trinitrate in Treatment of Chronic Anal Fissure

CompletedNCT03528772

Mansoura UniversityAnal Fissure

Start: 2018-05-10End: 2019-09-30Updated: 2019-10-07

Related Papers

Randomized controlled trial on the efficacy and safety of the combination therapy of topical 0.1% finasteride - 5% Minoxidil in male androgenetic alopecia.

2025-04-101 citations

Topical 5% minoxidil versus topical 0.2% glyceryl trinitrate in treatment of chronic anal fissure: A randomized clinical trial

International Journal of Surgery2020-02-0410 citations

Minoxidil versus placebo in the treatment of arterial wall hypertrophy in children with Williams Beuren Syndrome: a randomized controlled trial.

2019-05-2810 citations